New Results
In Vivo Blunt-End Cloning Through CRISPR/Cas9-Facilitated Non-Homologous End-Joining
Jonathan M. Geisinger, Sören Turan, Sophia Hernandez, Laura P. Spector, Michele P. Calos
doi: https://doi.org/10.1101/019570
Jonathan M. Geisinger
Department of Genetics, Stanford University School of Medicine, Stanford, California, United States
Sören Turan
Department of Genetics, Stanford University School of Medicine, Stanford, California, United States
Sophia Hernandez
Department of Genetics, Stanford University School of Medicine, Stanford, California, United States
Laura P. Spector
Department of Genetics, Stanford University School of Medicine, Stanford, California, United States
Michele P. Calos
Department of Genetics, Stanford University School of Medicine, Stanford, California, United States
Article usage
Posted May 21, 2015.
In Vivo Blunt-End Cloning Through CRISPR/Cas9-Facilitated Non-Homologous End-Joining
Jonathan M. Geisinger, Sören Turan, Sophia Hernandez, Laura P. Spector, Michele P. Calos
bioRxiv 019570; doi: https://doi.org/10.1101/019570
Subject Area
Subject Areas
- Biochemistry (11573)
- Bioengineering (8623)
- Bioinformatics (28874)
- Biophysics (14805)
- Cancer Biology (11944)
- Cell Biology (17170)
- Clinical Trials (138)
- Developmental Biology (9306)
- Ecology (14022)
- Epidemiology (2067)
- Evolutionary Biology (18129)
- Genetics (12148)
- Genomics (16619)
- Immunology (11709)
- Microbiology (27697)
- Molecular Biology (11392)
- Neuroscience (60106)
- Paleontology (447)
- Pathology (1849)
- Pharmacology and Toxicology (3184)
- Physiology (4878)
- Plant Biology (10279)
- Synthetic Biology (2849)
- Systems Biology (7291)
- Zoology (1619)